CTHRC1 overexpression predicts poor survival and enhances epithelial-mesenchymal transition in colorectal cancer.

CTHRC1 overexpression predicts poor survival and enhances epithelial-mesenchymal transition in colorectal cancer.
复制标题

CTHRC1 过表达可预测结直肠癌的不良生存并增强上皮间质转化

DOI:
10.1002/cam4.1807
复制
发表时间:
2018-11
期刊:
影响因子:
4
通讯作者:
Huang D
Huang D
中科院分区:
医学3区
文献类型:
--
作者:
Ni S;Ren F;Xu M;Tan C;Weng W;Huang Z;Sheng W;Huang D

文献摘要

参考文献

被引文献

相似文献

含胶原蛋白三螺旋重复序列(CTHRC1)是一种趋化蛋白,参与血管重塑、抗纤维化、代谢、骨形成和癌症等多个过程,是一种肿瘤相关因子。本研究旨在探讨CTHRC1在结直肠癌上皮-间充质转化(EMT)过程中的临床意义和可能作用。在这里,我们发现与配对的非癌组织相比,结直肠癌组织中CTHRC1mRNA和蛋白水平均上调。此外,结直肠癌(尤其是结肠癌)中CTHRC1的过度表达与预后不良有关。此外,我们还发现CTHRC1诱导了结直肠癌细胞的EMT,并促进了细胞的运动。重要的是,我们证明了CTHRc1通过激活转化生长因子-β(转化生长因子-β)信号来促进EMT,为结直肠癌患者提供了一种可能的有效治疗方法。
Collagen triple helix repeat containing (CTHRC1), which was identified as a cancer‐related factor, is a promigratory protein involved in multiple processes, including vascular remodeling, antifibrosis, metabolism, bone formation, and cancer. In this study, we aimed to investigate the clinical significance and possible role of CTHRC1 in the process of epithelial‐mesenchymal transition (EMT) in colorectal cancer (CRC). Here, we revealed that CTHRC1 mRNA and protein levels are both upregulated in CRC tissues compared with those of paired noncancerous tissues. Moreover, the overexpression of CTHRC1 correlated with poor prognosis in patients with CRC (especially colon cancer). Furthermore, we showed that CTHRC1 induced EMT and promoted cell motility in CRC cells. Importantly, we demonstrated that CTHRC1 promoted EMT by activating transforming growth factor‐β (TGF‐β) signaling, revealing a possible effective therapeutic treatment for patients with CRC.
DOI: 10.1016/j.devcel.2008.05.007
发表时间: 2008-07-01
期刊: DEVELOPMENTAL CELL
影响因子: 11.8
作者:
Yamamoto, Shinji;Nishimura, Osamu;Sasaki, Hiroshi
通讯作者: Sasaki, Hiroshi
DOI: 10.1186/1471-2482-12-16
发表时间: 2012-08-06
期刊: BMC surgery
影响因子: 1.9
作者:
Kye BH;Jung JH;Kim HJ;Kang SG;Cho HM;Kim JG
通讯作者: Kim JG
DOI: 10.18632/oncotarget.1714
发表时间: 2014-01-30
期刊: Oncotarget
影响因子: --
作者:
Kim HC;Kim YS;Oh HW;Kim K;Oh SS;Kim JT;Kim BY;Lee SJ;Choe YK;Kim DH;Kim SH;Chae SW;Kim KD;Lee HG
通讯作者: Lee HG
DOI: 10.3892/ijo.2014.2445
发表时间: 2014-08
影响因子: 5.2
作者:
Tameda M;Sugimoto K;Shiraki K;Yamamoto N;Okamoto R;Usui M;Ito M;Takei Y;Nobori T;Kojima T;Suzuki H;Uchida M;Uchida K
通讯作者: Uchida K
DOI: 10.18632/oncotarget.7604
发表时间: 2016-03-22
期刊: Oncotarget
影响因子: --
作者:
Eriksson J;Le Joncour V;Nummela P;Jahkola T;Virolainen S;Laakkonen P;Saksela O;Hölttä E
通讯作者: Hölttä E